University of California at Los Angeles UCLA New SC Address — Los Angeles, California

University of California at Los Angeles UCLA New SC Address is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of California at Los Angeles UCLA New SC Address has participated in 1 clinical trials.

Therapeutic areas: Carcinoid Tumor, Malignant Carcinoid Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California at Los Angeles UCLA New SC Address?

University of California at Los Angeles UCLA New SC Address has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California at Los Angeles UCLA New SC Address conducted?

University of California at Los Angeles UCLA New SC Address has 1 clinical trials on record. Their work covers Carcinoid Tumor, Malignant Carcinoid Syndrome.

Is University of California at Los Angeles UCLA New SC Address accredited by Crixeo Health?

University of California at Los Angeles UCLA New SC Address has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California at Los Angeles UCLA New SC Address?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.